ICAM1 and type 2 diabetes mellitus: Similarly, there were no significant differences in the VCAM-1 (3119 ± 2095 ng/mL in T2D group vs. 2574 ± 1598 ng/mL in ND group, p = 0.43) and ICAM-1 (551 ± 449 ng/mL in T2D group vs. 581 ± 442 ng/mL in ND group, p = 0.43) levels between T2D and ND patients.